Polycarbonate Ultracentrifuge Tube Re-Use in Proteomic Analyses of Extracellular Vesicles
March 8th, 2024
A detailed protocol is provided for cleaning and re-using polycarbonate ultracentrifuge tubes to perform extracellular vesicle isolation suitable for proteomics experiments.
We study cardiovascular diseases, specifically the role of extracellular vesicles in the pathological calcification of cardiovascular tissues, such as valves and blood vessels. Researchers in our group have recently defined methods to extract tissue and trapped extracellular vesicles from fibro calcific cardiovascular tissue to determine their proteomic profile. Our group has demonstrated that these extracellular vesicles contain important protein cargo for initiating calcification in diseased tissues.
The specialized tubes used in the ultracentrifugation step of extracellular vesicle isolation can be cleaned and sterilized for reuse. However, proteomic analysis requires special consideration as any contamination could greatly affect downstream results. Here, we validate a protocol for reusing consumables, specifically polycarbonate ultracentrifuge tubes for extracellular vesicle isolation that is suitable for downstream, low input proteomics applications.
Our protocol is simple and effective and it will allow researchers to reduce both the consumable costs and the waste typically associated with these isolation protocols. To begin, gather used polycarbonate tubes and discard the previous sample thoroughly. To prevent drying of the sample to the side of the tube, immediately submerge the ultracentrifuge tubes in tap water.
Then incubate the tube in 0.1%sodium dodecyl sulfate, or SDS, for 10 minutes. Decant most, but not all of the SDS solution from the tube. And using a cotton swab thoroughly wipe the area of the tube that had the extracellular vesicle pellet.
To rinse, fill the tube with hot tap water and decant completely. After three rinses using a spray bottle, spray demineralized water into the tube followed by 70%ethanol. Place the tube upside down to dry completely and transfer it to a clean jar for reuse.
Overview
This study focuses on the role of extracellular vesicles in cardiovascular diseases, particularly their involvement in the calcification of cardiovascular tissues. The researchers demonstrate an effective protocol for cleaning and reusing polycarbonate ultracentrifuge tubes for isolating these vesicles, ensuring their applicability in proteomics while minimizing waste and costs.
Key Study Components
Research Area
- Cardiovascular diseases
- Extracellular vesicles
- Proteomics
Background
- Extracellular vesicles play a critical role in the calcification of cardiovascular tissues.
- Proper isolation is essential for accurate proteomic analysis.
- Contamination during isolation can significantly impact results.
Methods Used
- Cleaning and sterilization of polycarbonate ultracentrifuge tubes
- Usage of tissues from fibro calcific cardiovascular systems
- Protocol validation for low input proteomic applications
Main Results
- Validated a simple and effective method for reusing ultracentrifuge tubes.
- Ensured integrity and reliability of proteomic analysis.
- Reduced costs and waste associated with consumables in the process.
Conclusions
- The study presents a viable method for reusing ultracentrifuge tubes, which is significant for proteomics in cardiovascular research.
- This approach contributes to more sustainable laboratory practices in biology research.
Frequently Asked Questions
Executive Industry Relevance
Validated re-use of polycarbonate ultracentrifuge tubes in extracellular vesicle (EV) proteomics addresses both sustainability and cost-efficiency challenges in discovery-stage workflows. Ensuring minimal contamination and compatibility with mass spectrometry enables reliable protein identification from low-yield EV samples. This protocol supports enterprise R&D by reducing consumable waste without compromising analytical rigor or downstream data quality.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous hypothesis testing by minimizing background protein contamination in EV proteomics.
- Supports functional target validation through reliable protein cargo analysis from cardiovascular tissue-derived EVs.
- Facilitates biological de-risking by ensuring sample integrity across repeated isolations.
Screening & Assay Development
- Prepares validated, low-contaminant tubes for reproducible EV isolation and proteomic workflows.
- Standardizes sample preparation, reducing variability in downstream mass spectrometry assays.
- Enables scalable, cost-effective screening of EV protein content across multiple experiments.
Translational & Preclinical Research
- Aligns with translational biomarker discovery by supporting clean, reproducible EV proteome profiling.
- Maintains continuity from discovery through preclinical validation by minimizing synthetic polymer and protein carryover.
- Reduces risk of false positives in biomarker identification due to tube-derived contaminants.
Pipeline & Workflow Integration
This cleaning protocol integrates into the EV isolation and proteomics continuum, from early discovery through preclinical research, by ensuring sample purity and analytical compatibility.
- Discovery Biology: Supports robust hypothesis testing and pathway analysis by reducing confounding protein signals.
- Screening: Delivers assay-ready tubes with minimal background, enabling reliable comparative studies.
- Analytics: Provides quantitative mass spectrometry outputs with confirmed absence of polymer peaks.
- Translational Research: Facilitates reproducible EV protein profiling for biomarker alignment.
- Enterprise Reuse: Establishes a validated, reusable consumable workflow for ongoing EV proteomics studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in EV proteomics by minimizing contamination risk.
- Operational Value: Reduces consumable costs and laboratory waste through validated tube re-use.
- Strategic Value: Enables more experiments per budget, supporting capital-efficient R&D.
- Portfolio Impact: Improves risk-adjusted advancement decisions by ensuring data integrity across studies.
Implementation Considerations
- Requires expertise in proteomics and contamination control.
- Needs access to mass spectrometry and validated cleaning reagents.
- Demands cross-team standardization of cleaning and validation steps.
- May require adaptation for different EV sources or proteomic platforms.
- Limited to protocols where polymer and protein carryover can be analytically confirmed as negligible.
